StockNews.com initiated coverage on shares of Kamada (NASDAQ:KMDA – Free Report) in a research note published on Thursday morning. The brokerage issued a buy rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 target price on shares of Kamada in a report on Thursday, May 9th. View […]
StockNews.com assumed coverage on shares of Kamada (NASDAQ:KMDA – Free Report) in a report published on Thursday morning. The firm issued a buy rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and set a $11.00 price objective on shares of Kamada in a report on Thursday, May 9th. Check Out […]
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.